Levothyroxine in Pregnant SLE Patients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Levothyroxine

It is FDA approved drug for thyroid disease

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NYU Langone Health

OTHER

collaborator

Duke University

OTHER

collaborator

University of Chicago

OTHER

collaborator

Stanford University

OTHER

lead

Johns Hopkins University

OTHER